scholarly journals Selective activation of central thalamic fiber pathway facilitates behavioral performance in healthy non-human primates

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
A. P. Janson ◽  
J. L. Baker ◽  
I. Sani ◽  
K. P. Purpura ◽  
N. D. Schiff ◽  
...  

AbstractCentral thalamic deep brain stimulation (CT-DBS) is an investigational therapy to treat enduring cognitive dysfunctions in structurally brain injured (SBI) patients. However, the mechanisms of CT-DBS that promote restoration of cognitive functions are unknown, and the heterogeneous etiology and recovery profiles of SBI patients contribute to variable outcomes when using conventional DBS strategies,which may result in off-target effects due to activation of multiple pathways. To disambiguate the effects of stimulation of two adjacent thalamic pathways, we modeled and experimentally compared conventional and novel ‘field-shaping’ methods of CT-DBS within the central thalamus of healthy non-human primates (NHP) as they performed visuomotor tasks. We show that selective activation of the medial dorsal thalamic tegmental tract (DTTm), but not of the adjacent centromedian-parafascicularis (CM-Pf) pathway, results in robust behavioral facilitation. Our predictive modeling approach in healthy NHPs directly informs ongoing and future clinical investigations of conventional and novel methods of CT-DBS for treating cognitive dysfunctions in SBI patients, for whom no therapy currently exists.

2018 ◽  
Vol 51 (1) ◽  
pp. 41-52 ◽  
Author(s):  
Chellappan Praveen Rajneesh ◽  
Chien-Hung Lai ◽  
Shih-Ching Chen ◽  
Tsung-Hsun Hsieh ◽  
Hung-Yen Chin ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0160750 ◽  
Author(s):  
Mohammad Maarouf ◽  
Clemens Neudorfer ◽  
Faycal El Majdoub ◽  
Doris Lenartz ◽  
Jens Kuhn ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-12 ◽  
Author(s):  
Chalonda R. Handy ◽  
Christina Krudy ◽  
Nicholas Boulis

Chronic pain is experienced by as many as of cancer patients at some point during the disease. This pain can be directly cancer related or arise from a sensory neuropathy related to chemotherapy. Major pharmacological agents used to treat cancer pain often lack anatomical specificity and can have off-target effects that create new sources of suffering. These concerns establish a need for improved cancer pain management. Gene therapy is emerging as an exciting prospect. This paper discusses the potential for viral vector-based treatment of cancer pain. It describes studies involving vector delivery of transgenes to laboratory pain models to modulate the nociceptive cascade. It also discusses clinical investigations aimed at regulating pain in cancer patients. Considering the prevalence of pain among cancer patients and the growing potential of gene therapy, these studies could set the stage for a new class of medicines that selectively disrupt nociceptive signaling with limited off-target effects.


Neurosurgery ◽  
2008 ◽  
Vol 62 (5) ◽  
pp. E1182 ◽  
Author(s):  
Jens Kuhn ◽  
Doris Lenartz ◽  
Jürgen K. Mai ◽  
Wolfgang Huff ◽  
Joachim Klosterkoetter ◽  
...  

2016 ◽  
Vol 116 (5) ◽  
pp. 2383-2404 ◽  
Author(s):  
Jonathan L. Baker ◽  
Jae-Wook Ryou ◽  
Xuefeng F. Wei ◽  
Christopher R. Butson ◽  
Nicholas D. Schiff ◽  
...  

The central thalamus (CT) is a key component of the brain-wide network underlying arousal regulation and sensory-motor integration during wakefulness in the mammalian brain. Dysfunction of the CT, typically a result of severe brain injury (SBI), leads to long-lasting impairments in arousal regulation and subsequent deficits in cognition. Central thalamic deep brain stimulation (CT-DBS) is proposed as a therapy to reestablish and maintain arousal regulation to improve cognition in select SBI patients. However, a mechanistic understanding of CT-DBS and an optimal method of implementing this promising therapy are unknown. Here we demonstrate in two healthy nonhuman primates (NHPs), Macaca mulatta, that location-specific CT-DBS improves performance in visuomotor tasks and is associated with physiological effects consistent with enhancement of endogenous arousal. Specifically, CT-DBS within the lateral wing of the central lateral nucleus and the surrounding medial dorsal thalamic tegmental tract (DTTm) produces a rapid and robust modulation of performance and arousal, as measured by neuronal activity in the frontal cortex and striatum. Notably, the most robust and reliable behavioral and physiological responses resulted when we implemented a novel method of CT-DBS that orients and shapes the electric field within the DTTm using spatially separated DBS leads. Collectively, our results demonstrate that selective activation within the DTTm of the CT robustly regulates endogenous arousal and enhances cognitive performance in the intact NHP; these findings provide insights into the mechanism of CT-DBS and further support the development of CT-DBS as a therapy for reestablishing arousal regulation to support cognition in SBI patients.


2021 ◽  
Author(s):  
Nina M Rzechorzek ◽  
Michael J Thrippleton ◽  
Francesca M Chappell ◽  
Grant Mair ◽  
Ari Ercole ◽  
...  

ABSTRACTObjectiveTo determine the clinical relevance of brain temperature (TBr) variation in patients after traumatic brain injury (TBI).DesignCohort study with prospective (healthy participant) and retrospective (TBI patient) arms.SettingSingle neuroimaging site in the UK (prospective arm); intensive care sites contributing to the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) High Resolution ICU (HR ICU) Sub-Study (retrospective arm).Participants40 healthy adults aged 20-40 years recruited for non-invasive brain thermometry and all patients up to May 2020 that had TBr measured directly and were not subjected to Targeted Temperature Management (TTM).Main outcome measuresA diurnal change in TBr (healthy participants); death in intensive care (patients).ResultsIn healthy participants, mean TBr (38.5 SD 0.4°C) was higher than oral temperature (36.0 SD 0.5°C), and 0.36°C higher in luteal females relative to follicular females and males (95% confidence interval 0.17 to 0.55, P=0.0006 and 0.23 to 0.49, P<0.0001, respectively). TBr increased with age, most notably in deep brain regions (0.6°C over 20 years; 0.11 to 1.07, P=0.0002). The mean maximal spatial TBr range was 2.41 (SD 0.46)°C, with highest temperatures in the thalamus. TBr varied significantly by time of day, especially in deep brain regions (0.86°C; 0.37 to 1.26, P=0.0001), and was lowest in the late evening. Diurnal TBr in cortical white matter across participants ranged from 37.0 to 40.3°C. In TBI patients (n=114), mean TBr (38.5 SD 0.8°C) was significantly higher than body temperature (TBo 37.5 SD 0.5°C; P<0.0001) and ranged from 32.6 to 42.3°C. Only 25/110 patients displayed a diurnal temperature rhythm; TBr amplitude was reduced in older patients (P=0.018), and 25/113 patients died in intensive care. Lack of a daily TBr rhythm, or an age increase of 10 years, increased the odds of death 12-fold and 11-fold, respectively (OR for death with rhythm 0.09; 0.01 to 0.84, P=0.035 and for death with ageing by 1 year 1.10; 1.05 to 1.16, P=0.0002). Mean TBr was positively associated with survival (OR for death 0.45 for 1°C increase; 0.21 to 0.96, P=0.040).ConclusionsHealthy TBr exceeds TBo and varies by sex, age, menstrual cycle, brain region, and time of day. Our 4-dimensional reference resource for healthy TBr can guide interpretation of TBr data in multiple clinical settings. Daily temperature variation is frequently disrupted or absent in TBI patients, in which TBr variation is of greater prognostic use than absolute TBr. Older TBI patients lacking a daily TBr rhythm are at greatest risk of death in intensive care. Appropriately controlled trials are needed to confirm the predictive power of TBr rhythmicity in relation to patient outcome, as well as the clinical utility of TTM protocols in brain-injured patients.RegistrationUK CRN NIHR CPMS 42644; ClinicalTrials.gov number, NCT02210221.SUMMARY BOXWhat is already known on this topicBrain temperature (TBr) can be measured directly in brain-injured patients via intracranial probe, but this method cannot be used in healthy individuals.TBr can be measured non-invasively using magnetic resonance spectroscopy (MRS), but this method is not appropriate for most brain-injured patients.Since physiological reference ranges for TBr in health have not been established, the clinical relevance of TBr variation in patients is unknown, and the use of TTM in neurocritical care remains controversial.What this study addsA reference map for healthy adult TBr at three clinically-relevant time points that can guide interpretation of TBr measured directly, or by MRS, in multiple clinical settings.Our results suggest that loss of diurnal TBr rhythmicity after TBI increases the odds of intensive care death 12-fold; some TTM strategies may be clinically inappropriate.


2021 ◽  
Author(s):  
Moataz Dowaidar

The invention/demonstration of RNA interference (RNAi) as a therapeutic agent has opened the doors to development/research. Clinical trials on siRNA usage demonstrate that it may be utilized as a safe, effective and well-tolerated drug to treat a range of illnesses, particularly cancer. The siRNA drug delivery technology is useful in that it is easy to build and alter to reach the target site. Despite great advances in creating effective in vivo siRNA administration, there are still several difficulties and hurdles to face in order to reach the optimum formulation in terms of selectivity, efficiency and security of delivery. Chemical modifications, liposome-mediated transport, polymeric nanoparticles, and conjugated nanoparticles can bypass this. These changes have minimized off-target effects at various places and positions, resulting in better siRNA duplex nuclease and heat stability. Nanoparticles linked to the targeted ligand improve the probability of tumor-specific receptor binding. Controlling siRNA specificity, intercellular trafficking and site-specific delivery are all issues in the siRNA delivery method. The next study should focus on the in vivo safety profiles of different delivery systems, as well as creating possible targeting techniques for siRNA distribution that would limit toxicity, off-target effects, and other concerns. It is also vital to optimize biodegradable and biocompatible delivery mechanisms for the practical usefulness of RNA-based cancer therapies.


2021 ◽  
Author(s):  
Michelle J Redinbaugh ◽  
Mohsen Afrasiabi ◽  
Jessica M Phillips ◽  
Niranjan A Kambi ◽  
Sounak Mohanta ◽  
...  

Anesthetic manipulations provide much-needed causal evidence for neural correlates of consciousness, but nonspecific drug effects complicate their interpretation. Evidence suggests that thalamic deep brain stimulation (DBS) can either increase or decrease consciousness, depending on the stimulation target and parameters. The putative role of the central lateral thalamus (CL) in consciousness makes it an ideal DBS target to manipulate circuit-level mechanisms in corticostriatothalamic (CST) systems, thereby influencing consciousness and related processes. We used multimicroelectrode DBS targeted to CL in macaques while recording from frontal, parietal, and striatal regions. DBS induced episodes reminiscent of absence epilepsy, here termed absence-like activity (ALA), with decreased behavior and vacant staring coinciding with low-frequency oscillations. DBS modulated ALA likelihood in a frequency-specific manner. ALA events corresponded to decreases in measures of neural complexity (entropy) and integration (Phi*), an index of consciousness, and substantial changes to communication in CST circuits. During ALA, power spectral density and coherence at low frequencies increased across CST circuits, especially in thalamoparietal and corticostriatal pathways. Decreased consciousness and neural integration corresponded to shifts in corticostriatal network configurations that dissociated parietal and subcortical structures. Overall, the features of ALA and implicated networks were similar to those of absence epilepsy. As this same multimicroelectrode DBS method, but at different stimulation frequencies, can also increase consciousness in anesthetized macaques, it can be used to flexibly address questions of consciousness with limited confounds, as well as inform clinical investigations of absence epilepsy and other consciousness disorders.


Sign in / Sign up

Export Citation Format

Share Document